Vikas Lifecare Q3 FY26: Loss widens as income falls; 9-month profit boosted by Ebix settlement

Financial Results for Q3 FY26

Vikas Lifecare Ltd released its financial results for the quarter and nine months ending December 31, 2025.
For the quarter, the company reported a standalone net loss of ₹14.72 Crores on total income of ₹96.39 Crores. The consolidated net loss for the quarter was ₹29.28 Crores.
Year-over-year, standalone total income decreased by 13.50%, and consolidated income fell by 16.53%.
Looking at the nine months ended December 31, 2025, standalone total income grew 35.44% to ₹459.49 Crores. The company recorded a standalone net profit of ₹109.42 Crores for this period, significantly boosted by 'Other Income' of ₹133.28 Crores from a settlement gain related to Ebix Inc.

Key Financial Trends and Investor Focus

The company's results reveal a stark contrast between its quarterly performance and its cumulative nine-month financials. While the nine-month profit is a key figure, it relies heavily on a one-time settlement gain, not growth from core business activities.
The persistent quarterly losses and declining year-over-year income raise questions about the core business's current performance. Investors will focus on the sustainability of profits and the company's strategy to achieve consistent profitability from its main operations.

Company Background and Recent Developments

Vikas Lifecare is part of a consortium acquiring Ebix Inc. for USD 361 million. The company contributed approximately ₹299 crore by July 2024 to secure a 51% stake in Ebix International Holdings Limited. A dispute with Eraaya Lifespaces over investment recovery was resolved through arbitration in July 2025.

Its subsidiary, Genesis Gas Solutions, is a key player in smart metering and holds a joint venture with Indraprastha Gas Ltd (IGL). However, the investment transfer in IGL Genesis Technologies Limited is still awaiting necessary approvals and outstanding conditions.

Vikas Lifecare also conducted significant related party transactions in the first half of FY26, which require shareholder approval.
In December 2025, the company received a favorable SEBI adjudication order concerning specific trading transactions.

Additionally, Vikas Lifecare received an Income Tax demand order of ₹22.99 crore in April 2026 and plans to appeal it. Financial figures for prior periods were restated due to adjustments from the Ebix settlement.

Key Matters for Shareholders

Shareholders are seeking clarity on the timeline and outcome of pending approvals for related party transactions.
The company needs to show progress in meeting conditions for the IGL Genesis Technologies investment.
Close monitoring of core business performance is crucial, given the reliance on 'Other Income' for the nine-month profit.
The Income Tax demand represents a potential financial obligation that investors will watch.

Potential Risks and Challenges

• Quarterly Losses: The company continues to report net losses on both standalone and consolidated bases for the current quarter.
• Pending Approvals: Shareholder consent for material related party transactions and the completion of the IGL Genesis Technologies investment remain outstanding.
• Tax Contingency: Vikas Lifecare faces an Income Tax demand of ₹22.99 crore and is appealing the order.
• Accounting Adjustments: Restatement of prior period financial figures suggests past accounting variations.

Peer Comparison

Vikas Lifecare operates a diversified business model spanning polymers, chemicals, FMCG, healthcare, and smart products. This broad operational scope makes direct comparison with focused peers challenging without segment-specific financial data.

Key Financial Metrics

• Standalone Nine-Month Total Income increased by 35.44% to ₹459.49 Crores for the period ended December 31, 2025, compared to the previous year.
• Consolidated Total Income decreased by 16.53% to ₹9,775.81 Lakhs for the quarter ended December 31, 2025, compared to the previous year.

Looking Ahead

• Shareholder meeting outcomes regarding related party transactions.
• Progress on the IGL Genesis Technologies investment completion.
• The outcome of the Income Tax appeal.
• Performance trends in core business segments against quarterly losses.
• Further updates on the integration and financial contribution from the Ebix acquisition.